| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund Reg (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.14 |
| Derivatives/Mutual Fund/ETF |
1.62 |
| Equity |
97.52 |
| Trep |
0.72 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
36.55% |
| Top 10 Holdings |
57.50% |
| Top 25 Holdings |
87.30% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
64.76 |
| Healthcare |
19.52 |
| Retail |
4.27 |
| Food Beverage & Tobacco |
2.01 |
| Chemicals |
1.99 |
| Debt MF |
1.62 |
| Industrial Products |
1.54 |
| Miscellaneous |
1.18 |
| FMCG |
1.16 |
| Agricultural & Farm Machinery |
1.09 |
| Cash |
0.86 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
0.00 |
| PE Ratio |
42.42 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD. |
9.21 |
| Sun Pharmaceutical Industries Limited |
8.40 |
| Apollo Hospitals Enterprise Limited |
6.80 |
| Piramal Pharma Limited |
6.21 |
| Aurobindo Pharma Limited |
5.93 |
| Torrent Pharmaceuticals Limited |
5.46 |
| Max Healthcare Institute Limited |
4.40 |
| Emcure Pharmaceuticals Limited |
3.79 |
| Rubicon Research Limited |
3.70 |
| Fortis Health Care Ltd |
3.60 |
| Neuland Laboratories Limited |
3.40 |
| Lupin Limited |
2.65 |
| IPCA Laboratories Limited |
2.45 |
| Zydus Wellness Limited |
2.00 |
| NAVIN FLUORINE INTERNATIONAL L |
1.99 |
| SANOFI CONSUMER HEALTHCARE |
1.98 |
| Vijaya Diagnostic Centre Limited |
1.97 |
| Glaxosmithkline Pharma Ltd |
1.94 |
| Godrej Consumer Products Limited |
1.93 |
| Glenmark Pharmaceuticals Limited |
1.88 |
| Bajaj Finserv Money Market Fund-Direct Plan-Growth |
1.62 |
| Dr Lal Path Labs Ltd |
1.57 |
| Shaily Engineering Plastics Limited |
1.54 |
| Abbott India Limited |
1.46 |
| Biocon Limited |
1.42 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
